We also showed that the severity of AKI could be lessened by (i) reducing MDSC infiltration with an anti-Gr-1 antibody (15) or (ii) by targeting human CRP with an antisense oligonucleotide (37). This evidence concerns the gene CRP and acute kidney injury.